BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25416055)

  • 1. Significant simultaneous changes in serum CA19-9 and CA125 due to prolonged torsion of mature cystic teratoma of the ovary.
    Suh DS; Moon SH; Kim SC; Joo JK; Park WY; Kim KH
    World J Surg Oncol; 2014 Nov; 12():353. PubMed ID: 25416055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and clinical significance of tumor markers in ovarian mature cystic teratoma.
    Chen JM; Gao HY; Wang Q; Li Q
    Clin Exp Obstet Gynecol; 2016; 43(3):397-400. PubMed ID: 27328499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective evaluation of tumor markers in ovarian mature cystic teratoma and ovarian endometrioma.
    Kataoka T; Watanabe Y; Hoshiai H
    J Obstet Gynaecol Res; 2012 Aug; 38(8):1071-6. PubMed ID: 22568880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated CA 19-9 levels in mature cystic teratoma of the ovary.
    Kyung MS; Choi JS; Hong SH; Kim HS
    Int J Biol Markers; 2009; 24(1):52-6. PubMed ID: 19404923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do high levels of CA 19-9 in women with mature cystic teratomas of the ovary warrant further evaluation?
    Ugur MG; Ozturk E; Balat O; Dikensoy E; Teke S; Aydin A
    Eur J Gynaecol Oncol; 2012; 33(2):207-10. PubMed ID: 22611965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CA19-9 elevation in ovarian mature cystic teratoma: discrimination from ovarian cancer - CA19-9 level in teratoma.
    Cho HY; Kim K; Jeon YT; Kim YB; No JH
    Med Sci Monit; 2013 Mar; 19():230-5. PubMed ID: 23539074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mature Cystic Teratoma of Ovary with Abnormally High Levels of Ca19-9: A Case Report.
    Sampaio J; Sarmento-Gonçalves I; Barros JM; Felix J; Tiago-Silva P
    Rev Bras Ginecol Obstet; 2016 Jul; 38(7):365-7. PubMed ID: 27434195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign teratoma in an 85-year-old woman.
    Takahashi K; Shinno T; Watanabe Y; Kurioka H; Miyazaki K
    Arch Gynecol Obstet; 2000 Apr; 263(4):188-90. PubMed ID: 10834329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic mass associated with raised CA 125 for benign condition: a case report.
    Asher V; Hammond R; Duncan TJ
    World J Surg Oncol; 2010 Apr; 8():28. PubMed ID: 20398372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of cancer antigen 125, cancer antigen 19-9, and the neutrophil-to-lymphocyte ratio to diagnose mature cystic teratoma with torsion.
    Wang YQ; Xia WT; Wang F; Zhuang XX; Zheng FY; Lin F
    Int J Gynaecol Obstet; 2017 Jun; 137(3):332-337. PubMed ID: 28273351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor markers in mature cystic teratomas of the ovary.
    Ustunyurt E; Gungor T; Iskender C; Ustunyurt BO; Bilge U; Mollamahmutoglu L
    Arch Gynecol Obstet; 2009 Feb; 279(2):145-7. PubMed ID: 18506458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case of mature cystic teratoma of the greater omentum misdiagnosed as ovarian cyst.
    Yoshida A; Murabayashi N; Shiozaki T; Okugawa T; Tabata T
    J Obstet Gynaecol Res; 2005 Oct; 31(5):399-403. PubMed ID: 16176507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical significance of CA19-9 in ovarian mature cystic teratoma.
    Fan JT; Yan HQ; Malla S; Fan YJ; Xu H; Li DH; Liu Y
    Clin Exp Obstet Gynecol; 2016; 43(4):522-525. PubMed ID: 29734540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CA19-9 may have clinical significance in mature cystic teratomas of the ovary.
    Dede M; Gungor S; Yenen MC; Alanbay I; Duru NK; Haşimi A
    Int J Gynecol Cancer; 2006; 16(1):189-93. PubMed ID: 16445632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoamputation of an ovarian mature cystic teratoma: a case report and a review of the literature.
    Lee KH; Song MJ; Jung IC; Lee YS; Park EK
    World J Surg Oncol; 2016 Aug; 14(1):217. PubMed ID: 27535361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple neuroectodermal tumors arising in a mature cystic teratoma of the ovary.
    Oláh KS; Needham PG; Jones B
    Gynecol Oncol; 1989 Aug; 34(2):222-5. PubMed ID: 2753429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of mature teratomas containing malignant elements.
    Hirai K; Ishiko O; Itoh F; Nakagawa E; Kanaoka Y; Sumi T; Ogita S
    Oncol Rep; 2000; 7(3):655-7. PubMed ID: 10767385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary malignant melanoma arising from ruptured ovarian mature cystic teratoma with elevated serum CA 19-9: a case report and review of literature.
    Choi WK; Lee DH; Cho DH; Jang KY; Kim KM
    BMC Womens Health; 2019 Nov; 19(1):149. PubMed ID: 31775731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gangliocytic paraganglioma arising from mature cystic teratoma of the ovary.
    Mahdavi A; Silberberg B; Malviya VK; Braunstein AH; Shapiro J
    Gynecol Oncol; 2003 Aug; 90(2):482-5. PubMed ID: 12893225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Grade Astrocytoma within a Mature Cystic Teratoma in an Adolescent Patient.
    Yoder N; Marks A; Hui P; Litkouhi B; Cron J
    J Pediatr Adolesc Gynecol; 2018 Jun; 31(3):325-327. PubMed ID: 29107097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.